Evaluation of Anti-inflammatory Activity of Seeds of Phalaris canariensis

Drug Research

Volumn 66, Issue 1, 2015, Pages 23-27

  Madrigales Ahuatzi, D ^a   Perez Gutierrez, R M ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

antiinflammatory; cytokine; Phalaris canariensis

Indexed keywords

ANTIINFLAMMATORY AGENT; CHLOROFORM; CHLOROFORM PHALARIS CANARIENSIS EXTRACT; CROTON OIL; DICLOFENAC; HEXANE; HEXANE PHALARIS CANARIENSIS EXTRACT; HISTAMINE; INDOMETACIN; INTERLEUKIN 1BETA; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; METHANOL; METHANOL PHALARIS CANARIENSIS EXTRACT; MYELOPEROXIDASE; NITRIC OXIDE; PLANT EXTRACT; PREDNISOLONE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CARRAGEENAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARRAGEENAN-INDUCED PAW EDEMA; CONTROLLED STUDY; DOSE RESPONSE; EAR EDEMA; ENZYME ACTIVITY; GRANULOMA; MACROPHAGE; MALE; MEDICINAL PLANT; NONHUMAN; PHALARIS CANARIENSIS; PLANT SEED; RAT; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; EDEMA; INFLAMMATION; METABOLISM; PHALARIS; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DINOPROSTONE; EDEMA; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LEUKOTRIENE B4; MACROPHAGES; MALE; PHALARIS; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84954371278     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0035-1548764     Document Type: Article

References (21)

1. FitzGerald G. A. Coxibs and cardiovascular disease. N Engl J Med: 2004; 351 1709 1711
2. Matus-Cadiz M. A., Hucl P. Rapid and effective germination methods for overcoming seed dormancy in annual Canarygrass. Crop Science: 1990; 45 1696 1703
3. Novas M. J., Jiménez A. M., Asuero A. O. Determination of antioxidant activity of canary seed infusions by chemiluminescence. J Anal Chem: 2004; 59 75 77 10.1023/B:JANC. 0000011672.20745.54
4. Estrada-Salas P. A., Montero-Morán G. M., Martínez-Cuevas P. P. et al. Characterization of antidiabetic and antihypertensive properties of canary seed (Phalaris canariensis L.) peptides. J Agric Food Chem: 2014; 62 427 133 10.1021/jf404539y
5. Perez GR M., Ahuatzi D. M., Horcacitas M. C. et al. Antiobesity and antidiabetic effects of the hexane extract from Phalaris canariensis in high-fat diet-induced obese mice and streptozotocin-induced diabetic mice. Evidence-Based Complemen Altern Med: 2014; ID 145901, 13 pages 10.1155/2014/145901
6. Lijun W., Curtis L. W. Recent advances in extraction of nutraceuticals from plants. Trends Food Sci Technol: 2006; 17 300 312
7. Washiyama M., Sasaki Y., Hosokawa T. et al. Anti-inflammatory constituents of Sappan lignum. Biol Pharm Bull: 2009; 32 941 944
8. Gupta M., Mazumdar U. K., Sivakumar T. et al. Evaluation of anti-inflammatory activity of chloroform Extract of Bryonia laciniosa in experimental animal models. Biol Pharm Bull: 2003; 26 1342 1344
9. Jing-Rong W., Hua Z., Zhi-Hong J. G. et al. In vivo anti-inflammnatory and analgesic activities of a purified saponin fraction derived from the root of Ilex pubescens. Biol Pharm Bull: 2008; 31 643 650
10. Van Arman C. G. Anti-inflammatory drugs. Clin Pharm Ther: 1974; 16 900 904
11. Bradley P. P., Priebat D. A., Chiristensen R. D. et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol: 1982; 78 206 209
12. Arrigoni-Martelli E., Bramm E. Investigations in the influence of cyclophosphamide gold odium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis. Agents Actions: 1975; 5 264 267
13. Bogdan C., Paik J., Vodovotz Y. et al. Contrasting mechanism for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem: 1992; 267 23301 23308
14. Ding A., Nathan C. F., Orayear J. et al. Macrophage deactivating factor and transforming growth factors β1, β2 and β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ J Immunol: 1990; 145 940 944
15. Dunne AM W. Pathophysiology: Concepts of Altered Health States with Contributors. ed. Porth C. M. Lippincott Philadelphia: 1990; 165 176
16. Recio M. C., Giner R. M., Manez S. et al. Structural requirements for the anti-inflammatory activity of natural triterpenoids. Planta Med: 1995; 61 182 185
17. Rotelli A. E., Guardia T., Juarez A. O. et al. Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res: 2003; 48 601 606
18. Luster M. L., Dean J. H., Boorman G. A. A cell mediated immunity and its application in toxicology. Environ Health Perspect: 1982; 43 31 36
19. Aggarwal B., Gutterman J. The Human Cytokines: Handbook of Basic and Clinical Research. Published by Malden, MA, U.S.A. Blackwell Publishers: 1992
20. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev: 2002; 13 135 141
21. Bakhle Y. S., Botting R. M. Cyclooxygenase-2 and its regulation in inflammation. Mediators Inflamm: 1996; 5 305 323